David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Bioethics 26 (6):296-304 (2011)
The debate over the host of moral issues that genetic enhancement technology (GET) raises has been significant. One argument that has been advanced to impugn its moral legitimacy is the ‘unfair advantage argument’ (UAA), which states: allowing access to GET to be determined by socio-economic status would lead to unjust outcomes, namely, create a genetic caste system, and with it the exacerbation and perpetuation of existing socio-economic inequalities. Fritz Allhoff has recently objected to the argument, the kernel of which is that it conflates the use of the technology with its distribution. GET, he argues, would generate unjust outcomes only if it is distributed according to principles of an unjust pattern of distribution; for if we can determine what constitutes a ‘just’ distributive scheme, then the technology can be allocated according to the principles of that scheme. In this paper I argue the following cluster of related claims: (1) both UAA and Allhoff's proposed distributive schemes ignore the importance of non-genetic factors in the development of an individual's characteristics and capacities; (2) if we accept the view that it is good to prevent unjust outcomes that arise because some have exclusive access to GET, then we have to accept wide-ranging distributive schemes; (3) by tracking genetic and non-genetic factors wide-ranging schemes do violate in some sense the widely shared value of neutrality in liberal democracies
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Dov Fox (2007). Luck, Genes, and Equality. Journal of Law, Medicine and Ethics 35 (4):712-726.
Lisa S. Parker (2012). In Sport and Social Justice, Is Genetic Enhancement a Game Changer? Health Care Analysis 20 (4):328-346.
Maxwell J. Mehlman (2005). Genetic Enhancement: Plan Now to Act Later. Kennedy Institute of Ethics Journal 15 (1):77-82.
David Resnik (1994). Debunking the Slippery Slope Argument Against Human Germ-Line Gene Therapy. Journal of Medicine and Philosophy 19 (1):23-40.
Fritz Allhoff (2005). Germ-Line Genetic Enhancement and Rawlsian Primary Goods. Kennedy Institute of Ethics Journal 15 (1):39-56.
Michael Fuchs (2012). Reshaping Human Intelligence: The Debate About Genetic Enhancement of Cognitive Functions. Human Reproduction and Genetic Ethics 16 (2):165-181.
Jason Borenstein (2009). The Wisdom of Caution: Genetic Enhancement and Future Children. Science and Engineering Ethics 15 (4):517-530.
Claudio M. Tamburrini (2007). What's Wrong with Genetic Inequality? The Impact of Genetic Technology on Elite Sports and Society. Sport, Ethics and Philosophy 1 (2):229 – 238.
William Gardner (1995). Can Human Genetic Enhancement Be Prohibited? Journal of Medicine and Philosophy 20 (1):65-84.
Colin Farrelly (2004). The Genetic Difference Principle. American Journal of Bioethics 4 (2):21 – 28.
Colin Farrelly (2007). Genetic Justice Must Track Genetic Complexity. Cambridge Quarterly of Healthcare Ethics 17 (01):45-53.
Joseph Kupfer (1993). The Ethics of Genetic Screening in the Workplace. Business Ethics Quarterly 3 (1):17-25.
Terrance Mcconnell (2011). Genetic Enhancement and Moral Attitudes Toward the Given. Journal of Applied Philosophy 28 (4):369-380.
Colin Farrelly (2002). Genes and Social Justice: A Rawlsian Reply to Moore. Bioethics 16 (1):72–83.
Added to index2011-02-15
Total downloads22 ( #77,650 of 1,100,838 )
Recent downloads (6 months)2 ( #176,557 of 1,100,838 )
How can I increase my downloads?